What's New on the FDA Drugs Site
February 9, 2017
- Exela Pharma Sciences, LLC Issues Voluntary Nationwide Recall of Ibuprofen Lysine Injection, 20 Mg/2 Ml (10 Mg/Ml) Due to Particulate Matter
- FDA approves Emflaza (deflazacort) to treat Duchenne muscular dystrophy
- FDA Drug Shortages
- Epinephrine Injection, 0.1 mg/mL (Updated - Discontinuation)
- Ranitidine Injection, USP (Updated - Currently in Shortage)
- La FDA advierte acerca de reacciones alérgicas poco comunes pero graves del antiséptico tópico con gluconato de clorhexidina
No hay comentarios:
Publicar un comentario